跳至主要内容
临床试验/EUCTR2020-005827-35-FR
EUCTR2020-005827-35-FR进行中(未招募)1 期

SARS-CoV-2 neurotropism, micRoglial ActivatioN and cytokine dySregulaTiOn in COVID-19 patients with delirium - BRAINSTORM

niversity Hospital of Toulouse0 个研究点目标入组 25 人开始时间: 2020年12月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Adult patients (male or female > or = 18 years)
  • - COVID-19 (positive respiratory track PCR test < 30 days)
  • - Delirium (CAM-ICU criteria)
  • - informed and written consent to participate in the study by patient’s surrogate
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • - medical decision of withdrawal of life sustaining treatments previous to patients recruitment
  • - former neurological or psychiatric disability
  • - MRI or PET scan contraindication
  • - pregnancy or breastfeeding
  • - hemodynamic or respiratory failure precluding patient’s transport / MRI or PET scanning

研究者

发起方
niversity Hospital of Toulouse

相似试验